- Home
- AVIR vs EMF Comparison
AVIR vs EMF Comparison
Compare AVIR & EMF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVIR
- EMF
- Stock Information
- Founded
- AVIR 2012
- EMF 1987
- Country
- AVIR United States
- EMF United States
- Employees
- AVIR N/A
- EMF N/A
- Industry
- AVIR Medicinal Chemicals and Botanical Products
- EMF Finance/Investors Services
- Sector
- AVIR Health Care
- EMF Finance
- Exchange
- AVIR Nasdaq
- EMF Nasdaq
- Market Cap
- AVIR 290.4M
- EMF 254.5M
- IPO Year
- AVIR 2020
- EMF N/A
- Fundamental
- Price
- AVIR $3.27
- EMF $17.85
- Analyst Decision
- AVIR Hold
- EMF
- Analyst Count
- AVIR 1
- EMF 0
- Target Price
- AVIR $6.00
- EMF N/A
- AVG Volume (30 Days)
- AVIR 453.6K
- EMF 29.3K
- Earning Date
- AVIR 11-07-2025
- EMF 01-01-0001
- Dividend Yield
- AVIR N/A
- EMF 6.16%
- EPS Growth
- AVIR N/A
- EMF N/A
- EPS
- AVIR N/A
- EMF N/A
- Revenue
- AVIR N/A
- EMF N/A
- Revenue This Year
- AVIR N/A
- EMF N/A
- Revenue Next Year
- AVIR N/A
- EMF N/A
- P/E Ratio
- AVIR N/A
- EMF N/A
- Revenue Growth
- AVIR N/A
- EMF N/A
- 52 Week Low
- AVIR $2.46
- EMF $10.58
- 52 Week High
- AVIR $4.02
- EMF $12.67
- Technical
- Relative Strength Index (RSI)
- AVIR 57.88
- EMF 73.02
- Support Level
- AVIR $3.15
- EMF $16.82
- Resistance Level
- AVIR $3.34
- EMF $18.01
- Average True Range (ATR)
- AVIR 0.10
- EMF 0.31
- MACD
- AVIR 0.02
- EMF 0.08
- Stochastic Oscillator
- AVIR 79.37
- EMF 91.77
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).
About EMF Templeton Emerging Markets Fund
Templeton Emerging Markets Fund is a closed-end management investment company. It seeks long-term capital appreciation by investing, under normal market conditions, at least 80% of its net assets in emerging country equity securities. It invests in various sectors such as Pharmaceuticals, Beverages, Broadline Retail, Metals &Mining, Banks, Food Products, Semiconductors & Semiconductor Equipment, insurance, Entertainment, and others.